Angiagenesis pathway gene polymorphisms associated with clinical outcome in recurrent ovarian cancer treated with low dose cyclophosphamide and bevacizumab: A California Consortium Trial. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Schultheis, AM
  • Yang, D
  • Garcia, AA
  • Morgan, R
  • Gandara, D
  • Scudder, S
  • Oza, A
  • Hirte, Holger
  • Fleming, G
  • Roman, L
  • Lenz, H

publication date

  • June 20, 2006